|
Mar 12
|
Clover Health Investments Corp (CLOV) Reports Significant Improvement in 2023 Financial Results
|
|
Mar 12
|
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
|
|
Mar 7
|
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
|
|
Feb 16
|
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
|
|
Jan 10
|
Clover Health Provides Business Update and Full-Year 2024 Objectives
|
|
Jan 10
|
BestGrowthStocks.Com Issues Extensive Comprehensive Analysis of Clover Health Investments, Corp.
|
|
Dec 21
|
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
|
|
Dec 18
|
Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
|
|
Dec 5
|
Clover Health Investments, Corp.'s (NASDAQ:CLOV) top owners are individual investors with 57% stake, while 23% is held by insiders
|
|
Dec 1
|
Clover Health Exits ACO REACH to Accelerate Path to Profitability
|
|
Apr 24
|
Clover Health Announces Agreement to Settle Securities Class Action Litigation
|